[Studies on the intradermal test of Clonorchis peptide(CPT) Antigen 1. Preliminary report].

Kisaengchunghak Chapchi

Department of Preventive Medicine, School of Medicine, Kyungpook National University, Korea.

Published: June 1965

AI Article Synopsis

  • The study isolated a polypeptide antigen (CPT) from Clonorchis sinensis adult worms using a diluted HCl-extraction method and tested its effectiveness in diagnosing clonorchiasis compared to other antigens (CPF and VBS).
  • The intradermal test showed a positive reaction in 42.7% of clonorchiasis patients when 1 microgram of CPT was injected, but the reaction was smaller in size than those from CPF and VBS antigens.
  • CPT antigen did not cross-react with patients suffering from other parasitic diseases like paragonimiasis and metagonimiasis, indicating its specificity for clonorchiasis.

Article Abstract

Polypeptide antigen as isolated from adult worms of Clonorchis sinensis by means of diluted HCl-extraction method. Preliminary intradermal examination with those polypeptide antigen(CPT) were performed on patients of clonorchiasis, paragonimiasis and metagonimiasis and the result of the intradermal test with CPT antigen were compared with those of Clonorchis protein fraction(CPF) and Veronal buffer saline extraction (VBS) antigen. The result of the examination were summerized as follows: 1. When 0.05 ml (1 microgram) of CPT was injected intradermally, the positive intradermal reaction appeared in 42.7 per cent (37 of 82) on the patients of clonorchiasis. 2. The sizes of the wheal and erythema with CPT antigen was smaller than that of CPF and VBS antigen. 3. Intradermal reaction with CPT antigen was carried out for other parasitic diseases, such as paragonimiasis and metagonimiasis. The result indicated that CPT antigen may be showed no cross reactions. 4. Clonorchiasis pateints who with negative reaction to CPT antigen, reacted negatively to CPF and VBS antigens.

Download full-text PDF

Source
http://dx.doi.org/10.3347/kjp.1965.3.1.39DOI Listing

Publication Analysis

Top Keywords

cpt antigen
20
antigen
9
intradermal test
8
patients clonorchiasis
8
paragonimiasis metagonimiasis
8
metagonimiasis result
8
vbs antigen
8
intradermal reaction
8
cpf vbs
8
reaction cpt
8

Similar Publications

In women globally, breast cancer ranks as the second most frequent cause of cancer-related deaths, making up about 25% of female cancer cases, which is pretty standard in affluent countries. Breast cancer is divided into subtypes based on aggressive, genetic and stage. The precise cause of the problem is still unknown.

View Article and Find Full Text PDF

Chemotherapy-induced neuropathic pain (CINP) is a prevalent side effect of chemotherapy. Total glucosides of paeony (TGP) have been shown to be effective in pain management. This study aimed to investigate the efficacy and mechanism of TGP in alleviating CINP.

View Article and Find Full Text PDF

Triglyceride (TG) and its derivatives tend to be decreased in rheumatoid arthritis (RA) patients' blood when inflammation progresses. Aside from the role as a lipid buffer, white adipose tissue (WAT) contributes to this abnormality via adipokines, which regulate many metabolic signals. This work investigated adipokine-caused hepatic changes and their involvement in RA-related hypolipemia.

View Article and Find Full Text PDF

The non-polymorphic HLA-E molecule offers opportunities for new universal immunotherapeutic approaches to chronic infectious diseases. Chronic Hepatitis B virus (HBV) infection is driven in part by T cell dysfunction due to elevated levels of the HBV envelope (Env) protein hepatitis B surface antigen (HBsAg). Here we report the characterization of three genotypic variants of an HLA-E-binding HBsAg peptide, Env identified through bioinformatic predictions and verified by biochemical and cellular assays.

View Article and Find Full Text PDF

Antitumor Effect of Peptide-Camptothecin Conjugate Targeting CD133 Protein.

Bioconjug Chem

November 2024

Yunnan Key Laboratory of Chiral Functional Substance Research and Application, Yunnan Minzu University, Kunming 650504, China.

The peptide-drug conjugate (PDC) has emerged as one of the new approaches for cancer therapy, which has the advantages of improved drug target ability and reduced adverse effects compared with the traditional chemotherapy. CD133 is a surface antigen specific to cancer stem cells, which are thought to be responsible for the self-renewal, proliferation, metastasis, and chemoresistance of cancer cells. A PDC for CD133 was designed by us, and it consists of CD133 targeting peptide LS-7 (amino acid sequence LQNAPRS), a pH-sensitive linker (succinyl), and a cytotoxic payload, the cytotoxic molecule camptothecin (CPT) with potent toxicity in vivo and in vitro.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!